BIBLIOGRAPHIC RECORD

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Concepción García; María Gómez‐Cañas; Sonia Burgaz; Belén Palomares; Yolanda Gómez‐Gálvez; Cristina Palomo‐Garo; Sara Campo; Joel Ferrer-Hernández; Carolina Pavicic; Carmen M. Navarrete; Maria Luz Bellido; Moisés Garcı́a-Arencibia; María Ruth Pazos; Eduardo Muñóz; Javier Fernández‐Ruíz
Source of metadata
OpenAlex
Year recorded
2018

Public identifiers and source

Open the source record

Reference

Concepción García; María Gómez‐Cañas; Sonia Burgaz; Belén Palomares; Yolanda Gómez‐Gálvez; Cristina Palomo‐Garo; Sara Campo; Joel Ferrer-Hernández; Carolina Pavicic; Carmen M. Navarrete; Maria Luz Bellido; Moisés Garcı́a-Arencibia; María Ruth Pazos; Eduardo Muñóz; Javier Fernández‐Ruíz. (2018). Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor. https://openalex.org/W2784023895

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-44d0078f373c1fc3a21f15a27c595118/